Breast biopsy utilization a population-based study

Archives of Internal Medicine

Volumn 165, Issue 14, 2005, Pages 1593-1598

  Ghosh, Karthik ^a   Joseph Melton III, L ^a   Suman, Vera J ^a   Grant, Clive S ^a   Sterioff, Sylvester ^a   Brandt, Kathy R ^a   Branch, Charles ^b   Sellers, Thomas A ^c   Hartmann, Lynn C ^a  

^a MAYO CLINIC   (United States)

^b OLMSTED MEDICAL CENTER   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BENIGN TUMOR; BREAST BIOPSY; BREAST CANCER; BREAST TUMOR; EXCISION; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INCIDENCE; MEDICAL RECORD; NEEDLE BIOPSY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW;

ADULT; BIOPSY, NEEDLE; BREAST; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 23744467281     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.165.14.1593     Document Type: Review

References (31)

1. Blackman DK, Bennett EM, Miller DS. Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)-Behavioral Risk Factor Surveillance System. MMWR CDC Surveill Summ. 1999;486:1-22.
2. Hall F. Screening mammography: potential problems on the horizon. N Engl J Med. 1986;314:53-55.
3. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338:1089-1096.
4. Steggles S, Lightfoot N, Sellick SM. Psychological distress associated with organized breast cancer screening. Cancer Prev Control. 1998;2:213-220.
5. Lidbrink E, Elfving J, Frisell J, Jonsson E. Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial. BMJ. 1996;312:273-276.
6. Parker SH. Percutaneous large-core breast biopsy. Cancer. 1994;74:256-262.
7. Parker SH, Lovin JD, Jobe WE, et al. Stereotactic breast biopsy with a biopsy gun. Radiology. 1990;176:741-747.
8. Gisvold JJ, Goellner JR, Grant CS, et al. Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques. AJR Am J Roentgenol. 1994;162:815-820.
9. Parker SH, Lovin JD, Jobe WE, Burke BJ, Hopper KD, Yakes WF. Nonpalpable breast lesions: stereotactic automated large-core biopsies. Radiology. 1991; 180:403-407.
10. Liberman L, Fahs MC, Dershaw DD, et al. Impact of stereotaxic core breast biopsy on cost of diagnosis. Radiology. 1995;195:633-637.
11. Ricci A, Banever T. Frequency of breast biopsy and breast cancer diagnosis in central Connecticut: trends from 1993 to 1997. Conn Med. 1998;62:143-147.
12. Hyser MJ, Vanuno D, Mallesh A, et al. Changing patterns of care for occult breast lesions in a community teaching hospital. Am Surg. 2000;66:438-442.
13. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266-274.
14. Melton LJ III. The threat to medical-records research. N Engl J Med. 1997;337: 1466-1470.
15. Bergstralh EJ, Offord KP, Chu C-P, Beard CM, O'Fallon WM, Melton LJ III. Calculating Incidence, Prevalence and Mortality Rates for Olmsted County, Minnesota: An Update. Rochester, Minn: Mayo Clinic; 1992. Technical Report Series, No. 49.
16. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics. 1955;2:375-385.
17. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
18. Kerlikowske K, Smith-Bindman R, Ljung BM, Grady D. Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med. 2003;139:274-284.
19. May DS, Lee NC, Nadel MR, Henson RM, Miller DS. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women. AJR Am J Roentgenol. 1998;170:97-104.
20. Kerlikowske K, Carney PA, Geller B, et al. Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med. 2000;133:855-863.
21. Kerlikowske K, Grady D, Barclay J, Sickles E, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA. 1993;270:2444-2450.
22. Eastman P. NCI adopts new mammography screening guidelines for women. J Natl Cancer Inst. 1997;89:538-539.
23. Kerlikowske K, Barclay J. Outcomes of modern screening mammography. J Natl Cancer Inst Monogr. 199722:105-111.
24. Blanchard DK, Donohue JH, Reynolds C, Grant CS. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg. 2003;138:482-488.
25. Barton MB, Elmore JG, Fletcher SW. Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med. 1999;130:651-657.
26. Wennberg J. Which rate is right? N Engl J Med. 1986;314:310-311.
27. Kim WR, Locke GR, Geier GR, et al. Utilization of colonoscopy in the community: a preliminary report [abstract]. Gastrointest Endosc. 1997;45:AB50.
28. Mangan TF, Larson DE, Melton LJ III, Zinsmeister AR. Use of gastroscopy in a community: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 1986;61:877-881.
29. Ballard DJ, Khanderia BK, Tajik AJ, Seward JB, Weber VP, Melton LJ III. Populationbased study of echocardiography: time trends in utilization and diagnostic profile of an evolving technology, 1975-1987. Int J Technol Assess Health Care. 1989;5:249-261.
30. Gabriel SE, O'Fallon WM, Beard CM, Kurland LT, Woods JE, Melton LJ III. Trends in the utilization of silicone breast implants, 1964-1991, and methodology for a population-based study of outcomes. J Clin Epidemiol. 1995;48:527-537.
31. Berg WA. Image-guided breast biopsy and management of high-risk lesions. Radiol Clin North Am. 2004;42:935-946.